After making its debut on Canada's NEO Exchange, MindMed made its Nasdaq debut. The mental health wellness company uses psychedelic substances as treatments for patients.

Psychedelics have made tremendous mainstream progress when it comes to the general public understanding the benefits, but Rahn said it's just "early innings for the entire industry and for our company" after becoming the first publicly traded psychedelics treatment company a year ago.

"For many, many years, solutions in the mental health space just really haven't been moving the needle in solving mental health for folks, and so what MindMed is doing is reimagining and reengineering how we are approaching mental health," CEO J.R. Rahn told Cheddar. "But we're doing it through substances like LSD, MDMA, psilocybin, these are psychedelics that from the 1960s were really demonized by society but we see great promise in what we call psychedelic-assisted therapy."

However, while marijuana legalization efforts have been going the route of deregulating for both medical and recreational purposes, Rahn said he doesn't believe the psychedelic industry should take the same path, touting the company's plan on sticking to FDA approval.

"I think the cannabis industry is vastly different than what we're trying to achieve here in the psychedelics medicine industry. There was a lot of mistakes made in cannabis. It's still not federally legal in the United States," he explained. "Our objective is to make these medicines accessible in all 50 states and all at the same time and do that in a scalable manner because 40 percent of the country needs these medicines. I think we are, as a company, going to stay away from legalization efforts and really just focus on the FDA pathway because that is how medicines ultimately get approved in the United States."

However, while he emphasized MindMed's approach through the U.S. government's regulatory framework, Rahn recognized that efforts to legalize and decriminalize psychedelics as the "voice of the people" hoping to find new solutions for mental health conditions.

MindMed trading under the ticker symbol MNMD closed at $4.02 per share on the day.

Updated on April 27, 2021, at 4:43 p.m. ET.

Share:
More In Business
Spain fines Airbnb $75 million for unlicensed tourist rentals
Spain's government has fined Airbnb 64 million euros or $75 million for advertising unlicensed tourist rentals. The consumer rights ministry announced the fine on Monday. The ministry stated that many listings lacked proper license numbers or included incorrect information. The move is part of Spain's ongoing efforts to regulate short-term rental companies amid a housing affordability crisis especially in popular urban areas. The ministry ordered Airbnb in May to remove around 65,000 listings for similar violations. The government's consumer rights minister emphasized the impact on families struggling with housing. Airbnb said it plans to challenge the fine in court.
Roomba maker iRobot files for bankruptcy protection; will be taken private under restructuring
Roomba maker iRobot has filed for Chapter 11 bankruptcy protection, but says that it doesn’t expect any disruptions to devices as the more than 30-year-old company is taken private under a restructuring process. iRobot said that it is being acquired by Picea through a court-supervised process. Picea is the company's primary contract manufacturer. The Bedford, Massachusetts-based anticipates completing the prepackaged chapter 11 process by February.
Serbia organized crime prosecutors charge minister, others in connection with Kushner-linked project
Serbia’s prosecutor for organized crime has charged a government minister and three others with abuse of position and falsifying of documents related to a luxury real estate project linked to U.S. President Donald Trump’s son-in-law Jared Kushner. The charges came on Monday. The investigation centers on a controversy over a a bombed-out military complex in central Belgrade that was a protected cultural heritage zone but that is facing redevelopment as a luxury compound by a company linked to Kushner. The $500 million proposal to build a high-rise hotel, offices and shops at the site has met fierce opposition from experts at home and abroad. Selakovic and others allegedly illegally lifted the protection status for the site by falsifying documentation.
Load More